Cardiovascular effects of inhaled ultrafine and nano-sized particles

INDICE: About the editors. Preface. Forword (Paul Borm). List of authors. Section I. Issue framing. 1. Overview. 2. Acute effects of particulate matter on cardiovascular events. 3. Chronic effects of particulate matter on cardiovascular disease. Section II. Exposure. 4. Particle characterization. 5. Exposureassessment ambient ultrafine particles. 6. From exposure to dose. 7. Translocation of Inhaled Nanoparticles. 8. Role of chemical composition in determiningthe cardiovascular effects of particles. Section III. Methodology. 9. In vitro studies. 10. Experimental studies in animals. 11. Human exposure studies. 12. Panel studies. Section IV. Particles and cardiovascular disease -mechanisms.A. ATHEROGENESIS. 13. Particulates and oxidative stress. 14. Role of inflammation in the atherogenic effects of particulate matter. 15. Inhaled particles, postprandial lipids and their possible contribution to atherogenesis. 16. Inhaled particulate matter and atherosclerosis in humans. B. VASCULAR DYSFUNCTION.17. Effects of particulates on the pulmonary vasculature. 18. Particulate Matter, Hypertension, and the Metabolic Syndrome. 19. Particles and the vascular endothelium. C. THROMBOSIS. 20. Particles, coagulation and thrombosis. 21. Particles and the pathogenesis of atherothrombosis. D. ARRHYTHMIA (NLM to edit). 22. Particles and the autonomic nervous system. 23. Air pollution and cardiac arrhythmia. Section V. Environmental and public health policy. 24. Risk assessment. 25. Environmental regulation of particulate matter. 26. From ambient ultrafine particles to nanotechnology and nanotoxicology.

• ISBN: 978-0-470-43353-9
• Editorial: John Wiley & Sons
• Encuadernacion: Cartoné
• Páginas: 604
• Fecha Publicación: 14/01/2011
• Nº Volúmenes: 1
• Idioma: Inglés